Top Markets
Coin of the day
Foresee Pharmaceuticals Co., Ltd. Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

6576
Rank in Stocks #14583
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Share Price
$2.58
Market Cap
$405.78M
Change (1 day)
-0.25%
Change (1 year)
1.54%
Country
TW
Trade Foresee Pharmaceuticals Co., Ltd. (6576)

Category

Earnings for Foresee Pharmaceuticals Co., Ltd. (6576)
Earnings in 2026 TTM: 0
According to Foresee Pharmaceuticals Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Foresee Pharmaceuticals Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors